Cigna Analysts Recommendations and Consensus

CI -- USA Stock  

USD 174.08  0.92  0.53%

The current analyst and expert consensus on Cigna is Buy with 1 strong sell and 7 strong buy opinions. The current projected target price consensus is 156.1 with 10 analysts opinions. The most common way Cigna analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Cigna executives and customers to further validate their buy or sell advice. Cigna buy or sell recommendation module provides average expert sentiment on the projected Cigna target price to derive its highest and lowest estimates based on projected price volatility of 23.091. Check also Macroaxis Advice on Cigna to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Cigna Target Price Consensus

Number of Opinions12
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

Cigna Target Price Projection

Current Price

Cigna Market Quote
Low Price173.92Odds
High Price176.06Odds

174.08

Target Price

Analyst Consensus On Target Price
Low Estimate99.0Odds
High Estimate172.0Odds
Number of Analysts10
Standard Deviation23.091

156.1

Cigna Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Current Thematic Trending
Manufacturing
Purchased over 100 shares
Traded over a week ago for 10.44
Manufacturing
Purchased over 300 shares
Traded over a week ago for 6.24
Investor Favorites
Purchased over 70 shares
Traded over a week ago for 23.42
Agribusiness Agriculture And Fishing
Purchased over 200 shares
Traded over a week ago for 8.1
Manufacturing
Purchased over 400 shares
Traded over a week ago for 4.74
Manufacturing
Purchased over 500 shares
Traded over a week ago for 3.42
Check also Macroaxis Advice on Cigna to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.